BIIB

Biogen Idec Inc. News Headlines

$291.48
*  
5.99
 negative 
2.1%
Get BIIB Alerts
*Delayed - data as of Apr. 16, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIIB After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Encouraging News for Alexion - Analyst Blog
9/16/2013 11:50:01 AM - Zacks.com

Data on MDCO's Oritavancin - Analyst Blog
9/16/2013 11:40:01 AM - Zacks.com

Biogen: All Reasons For Bulls To Be Happy
9/16/2013 11:38:00 AM - Seeking Alpha

Pipeline Progress at Gilead - Analyst Blog
9/16/2013 10:57:44 AM - Zacks.com

Data from Alexion's Soliris Study - Analyst Blog
9/13/2013 4:45:01 PM - Zacks.com

New Phase I data on Omeros' OMS824 - Analyst Blog
9/13/2013 11:57:50 AM - Zacks.com

Positive Results on Ventrus' Candidate, Shares Up - Analyst Blog
9/12/2013 4:57:44 PM - Zacks.com

Data on Actelion's Opsumit - Analyst Blog
9/12/2013 3:57:34 PM - Zacks.com

Loss Widens at Pluristem - Analyst Blog
9/12/2013 3:42:01 PM - Zacks.com

Gilead Seeks FDA Approval for Idelalisib - Analyst Blog
9/12/2013 10:58:17 AM - Zacks.com

FDA Panel Backs THRX/GSK Candidate - Analyst Blog
9/11/2013 6:58:03 PM - Zacks.com

Actelion to Start Cadazolid Phase III Studies - Analyst Blog
9/11/2013 6:57:16 PM - Zacks.com

Encouraging Data on Xenoport's XP23829 - Analyst Blog
9/11/2013 5:58:31 PM - Zacks.com

MEI Pharma Boosts Oncology Pipeline - Analyst Blog
9/11/2013 5:45:01 PM - Zacks.com

Gilead Sciences Offers A Challenge For The Individual Investor
9/11/2013 5:06:00 PM - Seeking Alpha

Biogen-Amicus in Parkinson's Deal - Analyst Blog
9/11/2013 12:57:38 PM - Zacks.com

Lannett Beats Q4 Earnings Estimates - Analyst Blog
9/11/2013 9:50:01 AM - Zacks.com

Rigel Pharma Trims Workforce - Analyst Blog
9/10/2013 6:45:01 PM - Zacks.com

Glaxo to Divest Lucozade and Ribena - Analyst Blog
9/10/2013 3:57:58 PM - Zacks.com

Biogen-Isis Team Up Again - Analyst Blog
9/10/2013 11:50:01 AM - Zacks.com

Company News for September 10, 2013 - Corporate Summary
9/10/2013 9:58:14 AM - Zacks.com

Peregrine Reports In-Line Loss - Analyst Blog
9/10/2013 8:57:36 AM - Zacks.com

Sector Update: Healthcare Edging Higher in Pre-Market
9/10/2013 8:14:35 AM - MT Newswires

Sector Update: Healthcare
9/10/2013 8:12:38 AM - MT Newswires

Pipeline Progress at AstraZeneca - Analyst Blog
9/9/2013 4:57:18 PM - Zacks.com